Leapmotor Debuts Global Product C10 and New Technologies at Munich, Launches Global Strategy
5.9.2023 20:27:00 EEST | Business Wire | Press release
On September 4th, Leapmotor made its debut at the IAA MOBILITY 2023 (hereinafter referred to as "Munich Motor Show"), where the "LEAP TOGETHER: Shaping a Shared Technological Future" global press conference was held. The event comprehensively showcased the latest achievement of all-domain in-house development, Leap 3.0 architecture, and the inaugural global model, the C10.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905065907/en/
C10 Model (Photo: Business Wire)
Leapmotor's Founder, Chairman, and CEO, Zhu Jiangming, emphasizes, “Leapmotor's globalization strategy encompasses the internationalization of both products and technology. Over 8 years of all-domain in-house development, Leapmotor has evolved from LEAP1.0 to LEAP3.0. With the arrival of our first global product based on LEAP3.0 architecture, the C10, all of Leapmotor's subsequent products will be designed and developed with a global mindset and adhere to global standards. In the next 2 years, Leapmotor will introduce 5 globally-oriented products in Europe, Asia-Pacific, the Middle East, the Americas, and other regions, offering intelligent mobility experiences to automotive consumers worldwide.”
As a technology-driven intelligent electric vehicle enterprise, Leapmotor remains steadfast in its commitment to all-domain in-house development of core technologies. With an unwavering commitment to shaping a shared future of intelligent mobility, Leapmotor remains devoted to delivering the finest smart mobility experience to all consumers.
Eight Years of All-domain In-house Development, LEAP 3.0 Embodies Cutting-Edge Intelligent Electric Technologies
Leap 3.0, with a central integrated electronic and electrical architecture as its core, encompasses several leading technologies, including CTC 2.0 (Cell-to-Chasis) technology, a latest oil-cooling electric drive, the intelligent cockpit with a Qualcomm Snapdragon 8295 chip, and a leading intelligent driving system. It is also built to global standards, and boasts an 88% interchangeability, imbuing each product with inherent intelligence, comfort, and safety traits.
Leapmotor's [Four-Leaf Clover] central integrated E/E architecture employs a central supercomputing platform, which seamlessly integrates the cockpit domain, pilot domain, power domain, and vehicle body domain, realizing the industry's pioneering convergence of these four domains. Furthermore, it enables vehicle-level seamless over-the-air (OTA) updates for five years. With over 500 reserved interfaces, it ensures Leapmotor to deliver an evolving and personalized driving experience.
Following last year's release of the package-less CTC technology, Leapmotor takes it a step further with CTC 2.0. This advanced technology eliminates modules, incorporates new safety features, and integrates a Battery Management System (BMS). This highly integrated battery-chassis equips the vehicle with attributes of extended range, enhanced safety, superior performance, and accelerated energy replenishment.
The latest oil-cooling electric drive features innovations that span from mid-voltage flat wire technology to high-voltage silicon carbide technology, offering power outputs ranging from 170kW to 250kW to accommodate both rear-wheel drive and all-wheel drive applications. The incorporation of high-voltage silicon carbide technology into the flat wire oil-cooling electric drive achieves a comprehensive efficiency of 92%, all while weighing only 76kg. This results in an ultra-compact and exceptionally powerful solution.
The Leapmotor intelligent cockpit system maximizes the capabilities of a Qualcomm Snapdragon 8295 chip, bestowing the cockpit with robust computing power and a seamless customer experience. The newly developed Leap OS intelligent desktop operating system caters to a multitude of driving scenarios, allowing customizable settings to accommodate diverse usage patterns.
At the intelligent driving level, the vehicle with Leap 3.0 is equipped with 30 high-performance perception hardware components, including LiDAR and an 8 million-pixel HD camera, delivering enhanced precision in perception. It is powered by an NVIDIA DRIVE Orin system-on-a-chip (SoC), which delivers 254 TOPS of computing to enable safe, high-speed and urban NAP intelligent-driving capabilities.
As an all-encompassing solution for intelligent electric vehicle technology, LEAP 3.0 stands as a prominent global leader in the field of intelligent electric vehicle technologies.
Leapmotor Initiates Globalization Strategy through Product Innovation and Technological Advancements
Leapmotor unveils C10 as the first model under LEAP3.0 architecture, marking its inaugural global strategic model. Embracing the signature design language of the Leapmotor family and leveraging the latest innovations of LEAP3.0, C10 embarks on an intelligent evolution to shape the future of mobility.
During the press conference, Mr. Zhu Jiangming stated, "Openness, co-creation, and global collaboration are key to achieving rapid proliferation of intelligent electric vehicles. Looking ahead, Leapmotor is not only an automobile manufacturer but also a comprehensive provider of intelligent electric vehicle solutions."
Globally, Leapmotor offers four different technology cooperation models, ranging from scratch to completion. Additionally, Leapmotor actively engages in strategic partnerships with world-renowned mobility ecosystem partners such as NVIDIA, ZF, Qualcomm, Bosch, and NXP.
The initiation of the global strategy is a critical step for Leapmotor as it leads the way with its competence of all-domain in-house development, driving the company's upward trajectory. It is also a demonstration of the synergy between brand strength, technological prowess, and influence.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905065907/en/
Contact information
Tammy Hu
hu_huiling@leapmotor.com
Lexi Liu
liu_xinyun@leapmotor.com
+86 15601869865
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
Cranium AI and ISTARI Forge Global Alliance to Drive Enterprise AI Security and Governance21.5.2026 13:00:00 EEST | Press release
Cranium AI, the leading end-to-end AI Security and Governance platform, and ISTARI, a leading cyber resilience advisory firm, today announced a strategic partnership to provide global organizations with an end-to-end AI security & governance solution. As organizations accelerate AI adoption, they face a critical challenge: implementing actionable, operational AI governance while keeping pace with the speed of the AI landscape. This collaboration bridges that gap by merging Cranium’s cutting-edge AI security and governance platform with ISTARI’s deep advisory expertise in cyber risk and operating model design. Together, the firms provide a powerful, end-to-end solution for enterprises navigating the complexities of AI transformation. A Unified Vision for Sustainable AI Governance The partnership is built on a shared mission to move organizations beyond fragmented AI initiatives toward fully operationalized, secure, and governed programs. By combining Cranium’s platform automation with I
Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 13:00:00 EEST | Press release
Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting to outcome-based software orchestration, the collaboration aims to deliver significant business value to ABB and Cognite customers, includin
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data underscore BeOne’s strategy to lead in hematology science and patient impact by setting the standard today – while helping to shape the future of CLL. Amit Agarwal, M.D., Ph.D., Chief Medic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom